Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene

Molecular and Biochemical Parasitology

Volumn 170, Issue 2, 2010, Pages 108-111

  Odom, Audrey R ^a   Van Voorhis, Wesley C ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Drug targets; Isoprenoid biosynthesis; Malaria

Indexed keywords

DEOXYXYLULOSE 5 PHOSPHATE REDUCTOISOMERASE; OXIDOREDUCTASE; PLASMID DNA; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA INTEGRATION; GENE ACTIVITY; GENE DISRUPTION; GENE LOCUS; GENETIC ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOAL GENETICS;

ALDOSE-KETOSE ISOMERASES; ANIMALS; ERYTHROCYTES; GENES, ESSENTIAL; GENES, PROTOZOAN; HUMANS; MULTIENZYME COMPLEXES; MUTAGENESIS, INSERTIONAL; OXIDOREDUCTASES; PLASMIDS; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

PLASMODIUM FALCIPARUM;

EID: 74849090103     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2009.12.001     Document Type: Article

References (19)

1. Hunter W.N. The non-mevalonate pathway of isoprenoid precursor biosynthesis. J Biol Chem 282 (2007) 21573-21577
2. Gershenzon J., and Dudareva N. The function of terpene natural products in the natural world. Nat Chem Biol 3 (2007) 408-414
3. Jomaa H., Wiesner J., Sanderbrand S., et al. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 285 (1999) 1573-1576
4. Cassera M.B., Gozzo F.C., D'Alexandri F.L., et al. The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum. J Biol Chem 279 (2004) 51749-51759
5. Rohdich F., Eisenreich W., Wungsintaweekul J., Hecht S., Schuhr C.A., and Bacher A. Biosynthesis of terpenoids. 2C-Methyl-d-erythritol 2,4-cyclodiphosphate synthase (IspF) from Plasmodium falciparum. Eur J Biochem 268 (2001) 3190-3197
6. Kuzuyama T., Takahashi S., and Seto H. Construction and characterization of Escherichia coli disruptants defective in the yaeM gene. Biosci Biotechnol Biochem 63 (1999) 776-778
7. Kuemmerle H.P., Murakawa T., Soneoka K., and Konishi T. Fosmidomycin: a new phosphonic acid antibiotic. Part I. Phase I tolerance studies. Int J Clin Pharmacol Ther Toxicol 23 (1985) 515-520
8. Missinou M.A., Borrmann S., Schindler A., et al. Fosmidomycin for malaria. Lancet 360 (2002) 1941-1942
9. Tahar R., and Basco L.K. Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-d-xylulose 5-phosphate reductoisomerase. Am J Trop Med Hyg 77 (2007) 214-220
10. Haemers T., Wiesner J., Giessmann D., et al. Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates. Bioorg Med Chem 16 (2008) 3361-3371
11. Kurz T., Behrendt C., Pein M., Kaula U., Bergmann B., and Walter R.D. gamma-Substituted bis(pivaloyloxymethyl)ester analogues of fosmidomycin and FR900098. Arch Pharm (Weinheim) 340 (2007) 661-666
12. Wiesner J., Ortmann R., Jomaa H., and Schlitzer M. Double ester prodrugs of FR900098 display enhanced in vitro antimalarial activity. Arch Pharm (Weinheim) 340 (2007) 667-669
13. Ortmann R., Wiesner J., Silber K., Klebe G., Jomaa H., and Schlitzer M. Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residues. Arch Pharm (Weinheim) 340 (2007) 483-490
14. Cassera M.B., Merino E.F., Peres V.J., Kimura E.A., Wunderlich G., and Katzin A.M. Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum. Mem Inst Oswaldo Cruz 102 (2007) 377-383
15. Sidhu A.B., Valderramos S.G., and Fidock D.A. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 57 (2005) 913-926
16. Proteau P.J. 1-Deoxy-d-xylulose 5-phosphate reductoisomerase: an overview. Bioorg Chem 32 (2004) 483-493
17. Brown A.C., and Parish T. Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake. BMC Microbiol 8 (2008) 78
18. Kobayashi K., Ehrlich S.D., Albertini A., et al. Essential Bacillus subtilis genes. Proc Natl Acad Sci USA 100 (2003) 4678-4683
19. Akerley B.J., Rubin E.J., Novick V.L., Amaya K., Judson N., and Mekalanos J.J. A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. Proc Natl Acad Sci USA 99 (2002) 966-971